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Abstract Tobacco-based transient expression was employed to
elucidate the impact of di¡erential targeting to subcellular com-
partments on activity and quality of gastric lipase as a model
for the production of recombinant glycoproteins in plants. Over-
all N-linked glycan structures of recombinant lipase were ana-
lyzed and for the ¢rst time sugar structures of its four individual
N-glycosylation sites were determined in situ by matrix-assisted
laser desorption/ionization time-of-£ight mass spectrometry
(MALDI-TOF-MS) on a trypsin digest without isolation or
deglycosylation of the peptides. Three glycosylation sites con-
tain both complex-type N-glycans and high-mannose-type struc-
tures, the fourth is exclusively linked to high-mannose glycans.
Although the overall pattern of glycan structures is in£uenced
by the targeting, our results show that the type of glycans found
linked to a given Asn residue is largely in£uenced by the phys-
ico-chemical environment of the site. The transient tobacco sys-
tem combined with MALDI-TOF-MS appears to be a useful
tool for the evaluation of glycoprotein production in plants.
, 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
The growing demand for safe protein drugs for human or
animal health has led to the development of several produc-
tion systems that are based on recombinant technologies for
gene expression. In addition to the more conventional fermen-
tation-based systems such as bacteria, yeast, insect- and mam-
malian cells, transgenic organisms have been employed for the
production of high-value recombinant proteins [1]. Transgenic
animal-based expression of recombinant proteins has been
demonstrated and some products have entered clinical devel-
opment [2,3]. Production of recombinant proteins in various
plant species has also been developed within the last decade,
and a ¢rst series of potential products has reached the clinic
[4].
Plant-based expression systems accumulate several advan-
tages as compared to other production systems, such as in-
creased biological safety, capacity to produce complex mole-
cules and last but not least the potential for highly economical
large-scale production of biopharmaceuticals [5]. This large-
scale production is based on the generation of stable trans-
formed plants that can be grown in greenhouses or open
¢elds.
The quality of a given recombinant product is largely in£u-
enced by the processing of the primary polypeptide chain,
such as the addition of necessary post-translational modi¢ca-
tions, among them N-linked glycosylation, by the host cell,
the capacity of the heterologous system to correctly fold the
peptide and, if required, to assemble multiple subunits into
functional hetero- or homo-multimers. In plants it is possible
to target proteins speci¢cally to the extracellular space (apo-
plast) or to subcellular organelles such as the vacuole, the
endoplasmic reticulum (ER) or to chloroplasts [6]. This will
in£uence the level of expression, the stability but also the
di¡erent post-translational modi¢cations of a given molecule.
The choice of subcellular targeting is therefore an important
decision during the strategy design for expression of a given
protein. Our aim was to develop a rapid tobacco-based tran-
sient expression system that allows the validation of the best
expression targeting hypothesis for a given candidate protein
within the shortest possible time and without generation of
stable transgenic plants. We have previously shown that an
adaptation of the agrobacterium in¢ltration technique [7] al-
lowed us to demonstrate the introduction of a post-transla-
tional modi¢cation pathway into tobacco cells by transient co-
expression of animal-derived prolyl-hydroxylase and its sub-
strate, collagen, to increase hydroxyprolin content and there-
by thermal stability of the collagen triple helix [8]. Vaquero et
al. have demonstrated with a similar system that di¡erent
expression approaches can be tested for recombinant antibod-
ies [9].
To further validate this transient expression system, notably
to produce su⁄cient amounts of the recombinant protein for
a detailed functional and structural analysis of the candidate
protein, we have studied recombinant dog gastric lipase (rGL)
as a model.
Gastric lipase (GL) is a 50 kDa glycoprotein with a poten-
tial interest as treatment of pancreatic insu⁄ciency linked to
cystic ¢brosis [10]. We have chosen this molecule as a model
for our analyses, since preliminary data in stable tobacco on
expression of gastric lipase that was either secreted or targeted
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to the vacuole were previously reported [11] and were avail-
able for comparison with results that we obtained by transient
expression. In addition, we show the in£uence of retention
within the ER on the structure and activity of rGL and
present for the ¢rst time a detailed analysis of N-linked glycan
structures on the di¡erentially targeted molecules of this re-
combinant enzyme by a combination of Fluorophore-assisted
carbohydrate (FACE) and matrix-assisted laser desorption/
ionization time-of-£ight mass spectrometry (MALDI-TOF-
MS) analyses.
2. Materials and methods
2.1. Plasmid constructs
cDNA encoding mature dog GL was fused to the signal peptide of
gastric lipase from rabbit (PS) for secretion targeting (s-rGL) [11]. For
targeting to the ER, a DNA fragment encoding the KDEL tag was
fused to the C-terminal end of the coding region (r-rGL) by polymer-
ase chain reaction (PCR). For vacuolar targeting the C-terminal pro-
peptide of barley lectin [12] was ampli¢ed by PCR and fused to the
coding region of lipase (v-rGL). The coding regions were placed under
the control of the enhanced 35S promoter (ep35S) [13,14] and 35S
terminator (t35S) of cauli£ower mosaic virus [15] in the plant expres-
sion plasmid pGAZE derived from pGA492 [16]. Constructs were ¢rst
cloned in Escherichia coli strain DH5K, using standard techniques
[17]. After control by DNA sequencing the plasmids were transferred
into Agrobacterium tumefaciens strain LBA4404 [18] to obtain strains
A746, A711 and A732 containing T-DNA encoding respectively
s-rGL, r-rGL and v-rGL.
2.2. Agroin¢ltration of tobacco leaves
Tobacco plants were agroin¢ltrated according to the protocol of
Kapila et al. [7]. Plant tissue was harvested for extraction 4 days after
transformation as described in Merle et al. [8].
2.3. Extraction and puri¢cation of rGL
Frozen agroin¢ltrated tobacco leaves were ground in liquid N2 and
macerated at 4‡C in 250 mM NaCl, 50 mM glycine, 1 mM Triton
X100 pH 2.5 (1 g of leaf material per 2 ml of extraction solution) for
1 h. Crude extract was clari¢ed by centrifugation at 42 000Ug. The
sample was loaded onto a cation exchange sulfopropyl ceramic hy-
perD column (Cyphergen Biosystems, Biosepra, Fremont, CA, USA)
bu¡ered with 50 mM glycine, 100 mM NaCl, pH 2.5. The protein was
eluted with 500 mM NaCl, 50 mM sodium acetate, pH 4.0 and loaded
on 500 Wl Fractogel EMD chelate charged with Cu2þ (Merck, White-
house Station, NJ, USA) in a Microbio Spin column (Bio-Rad, Her-
cules, CA, USA) equilibrated with 500 mM NaCl, 50 mM sodium
acetate, pH 4.0. Elution was performed with 1.2 M ammonium ace-
tate, 10 mM glycine pH 2.8. Fractions containing rGL were dialyzed
against 20 mM citric acid pH 4.0. The pure product was obtained by
collecting the rGL peak in RP-HPLC fractionation on a C4 column
(Vydac, Hesperia, CA, USA) (150 mmU4.6 mm).
2.4. Determination of speci¢c lipase activity
GL activity was measured using a pH Stat (718 STAT titrino;
Methrom, Switzerland) at pH 5.5. Short-chain triacylglycerol (tribu-
tyrin, Fluka, St. Louis, MO, USA) was used as substrate. Lipolytic
activity was measured at 37‡C in the conditions described by Gar-
gouri et al. [19]. One lipase unit is the amount of enzyme which
catalyzes the release of 1 Wmol of fatty acid per min.
2.5. Protein analysis by SDS^PAGE and N-terminal sequencing
Di¡erent forms of GL were analyzed on 12% SDS^PAGE gel ac-
cording to Laemmli et al. [20]. The gel was stained with Coomassie
blue. N-terminal sequencing was performed by automated Edman
degradation on a Procise 491 sequencer (Applied Biosystems, Fra-
mingham, MA, USA).
2.6. FACE analysis of rGL N-glycans
100 Wg of each of the di¡erent puri¢ed rGLs was used for N-glycan
analysis. N-glycans from horseradish peroxidase and ribonuclease B
(Sigma, St. Louis, MO, USA) were used as reference structures.
N-glycans were released with PNGase A (Roche, Basel, Switzerland)
after digestion of glycoproteins by trypsin (Sigma). N-glycans were
puri¢ed by successive elution with water on a Sep-Pack Vac C18
cartridge and Fractogel EMD SO33 and evaporated. N-glycans
were labeled with 8-aminonaphtalene-1,3,6-trisulfonate (ANTS; Mo-
lecular Probes, Eugene, OR, USA) according to Jackson et al. [21]. A
standard ladder of glucose oligomers was obtained from wheat starch
digest that was labeled with ANTS [22]. ANTS-oligosaccharides were
loaded on a 30% polyacrylamide gel without SDS and subjected to
separation at 4‡C. They were visualized under UV light. Each oligo-
saccharide band was assigned by calculating its degree of polymeriza-
tion value (DP) using the standard ladder of glucose oligomers [23]
and con¢rmed using oligosaccharides released from ribonuclease B
and horseradish peroxidase. The assignment was con¢rmed by MS
after elution of each oligosaccharide from the gel [24].
2.7. Mass spectrometry
MALDI mass spectra were acquired on a Voyager DE-PRO TOF
mass spectrometer (Applied Biosystems) equipped with a delayed ex-
traction MALDI source and a pulsed nitrogen laser (337 nm).
Carbohydrate analysis of the ANTS-labeled oligosaccharides was
performed according to the published procedure [24] in a negative
linear delayed extraction mode.
Analysis of the intact molecules was done in a positive linear de-
layed extraction mode. All spectra were acquired using an accelerating
voltage of 25 kV, a pulse delay time of 600 ns and a grid voltage of
93%. About 200 scans were averaged for each spectrum to improve
signal-to-noise level. Protein samples (10^30 WM) in 0.1% aqueous
TFA solution were mixed with a matrix solution and deposited
onto a stainless-steel target according to the dried droplet method.
The matrix solutions were prepared by dissolving 3,5-dimethoxy-4-
hydroxycinnamic acid (sinapinic acid, SIN; Acros Organics, Van
Overbeek, Belgium) in CH3CN/water (30:70 or 50:50, v/v) containing
0.1% TFA at a concentration of 15 Wg/Wl, or 2,5-dihydroxybenzoic
acid (DHB; Acros Organics) in CH3CN/water (30:70 or 50:50, v/v)
containing 0.1% TFA at a concentration of 10 Wg/Wl. Calibration was
performed in a close external mode using bovine serum albumin
(BSA; singly charged Mþ and doubly charged M2þ) ions.
For analysis of the glycopeptides, the puri¢ed protein was dissolved
in CH3CN (10% v/v, ¢nal concentration) and diluted with 25 mM
ammonium hydrogenocarbonate, pH 8.2, containing 1 mM calcium
chloride. Reductively alkylated porcine trypsin (Promega, Madison,
WI, USA), dissolved in the same bu¡er, was added to the protein at a
molar enzyme/substrate ratio of 1/20 and the solution was incubated
at 37‡C for 16 h. The tryptic digests (20 pmol/Wl) in the digest solu-
tions were diluted to a ¢nal concentration of 10 pmol/Wl in the matrix
solution. Sample preparation was carried out according to the dried
droplet method, using SIN and DHB as matrices. The matrix solu-
tions were prepared as for the analysis of the intact molecule.
Spectra were obtained in positive re£ector mode with an accelerat-
ing voltage of 25 kV, a pulse delay time of 250 ns and a grid voltage
of 75%. Spectra were averaged from about 200 laser shots to improve
signal-to-noise level. Mass assignment was done using a peptide mix-
ture (insulin B chain, bovine insulin, aprotinin and ubiquitin; Laser-
Bio Labs, Sophia-Antipolis, France) as external standards. A trypsin
autodigestion peptide (m/z=5561.2) was also used as an internal cal-
ibration standard.
3. Results
3.1. Production of s-rGL, r-rGL and v-rGL in tobacco leaves
Three di¡erent expression cassettes for di¡erential targeting
of rGL in transient expression in tobacco leaves were gener-
ated (Fig. 1A). The coding region of mature dog GL [25] was
fused to the signal peptide of GL from rabbit to assure secre-
tion out of the cell. This construct was termed s-rGL. A
fusion of this construct with the C-terminal propeptide of
barley lectin was generated for targeting to the vacuole
(v-rGL). A third construct was generated by fusion of the
C-terminal KDEL (Lys-Asp-Glu-Leu) sequence to the coding
region of GL to assure retention in the ER [26]. Transcription
of all constructs was driven from the enhanced 35S promoter
of cauli£ower mosaic virus and transcription was terminated
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using the t35S termination sequence. An Agrobacterium-medi-
ated transient system [7] was used to express s-rGL, r-rGL
and v-rGL after vacuum in¢ltration of tobacco leaves. Extrac-
tion and puri¢cation of the rGLs were carried out 4 days after
agroin¢ltration. Between 0.5 and 1 mg of recombinant protein
per 100 g of fresh leaves were puri¢ed. A detailed structural
and functional analysis of the three di¡erent lipase forms was
performed.
3.2. Comparison of catalytic activities of s-rGL, r-rGL and
v-rGL in tobacco leaves
The catalytic activities of recombinant rGLs after transient
expression were measured on short-chain triacylglycerols [19].
s-rGL is the most active recombinant protein with a speci¢c
activity of 360 U/mg. This activity is lower than but in the
same range as that observed for the native protein, which
reached 570 U/mg [27]. v-rGl exhibits two-fold less speci¢c
activity (140 U/mg) than s-rGL. Comparable values were ob-
served when the proteins were produced in stable tobacco [11],
thus showing a good equivalence between the transient and
stable tobacco expression systems. Speci¢c activity of r-rGL
was 310 U/mg, which is close to the activity of the secreted
form.
3.3. Primary structure of recombinant rGLs transiently
expressed in tobacco leaves
Puri¢ed rGLs were analyzed by SDS^PAGE (Fig. 1B) and
Western blot (data not shown). The recombinant proteins
were analyzed by MALDI-TOF-MS (Fig. 1C) and submitted
to N-terminal sequencing. Di¡erent patterns were obtained
according to the targeting of the protein. For s-rGL one ma-
jor molecular species was detected on SDS^PAGE and by
mass spectrometry, with a molecular weight around 49 kDa,
which is very close to the molecular weight of native dog GL
Fig. 1. Analysis of puri¢ed s-rGL, r-rGL and v-rGL. A: Schematic
representation of expression cassettes. The coding region of mature
dog GL is indicated as GL, the signal peptide from rabbit GL as
PS. KDEL represents the ER retention signal of r-rGL and BL the
vacuolar targeting peptide of v-rGL. ep35S is the enhanced 35S pro-
moter and t35S the 35S terminator of cauli£ower mosaic virus.
B: SDS^PAGE analyses. The puri¢ed proteins were analyzed on a
12% polyacrylamide gel, and stained with Coomassie blue. Size
markers for 50 and 40 kDa are indicated in the left margin.
C: MALDI-TOF mass spectra of the puri¢ed proteins using DHB
as matrix. The mass range 30 000^60 000 corresponds to rGL spec-
tra having singly charged ions. Indicated masses correspond to peak
centroids and were determined with an external calibration using
BSA (singly and doubly charged ions).
Fig. 2. FACE analysis. A: Comparison of FACE pro¢les of ANTS-
labeled N-glycans isolated from puri¢ed proteins. Lanes 1^3:
ANTS-labeled N-glycans isolated from respectively s-rGL, v-rGL
and r-rGL. Lane 4: standard ladder of glucose oligomers (G5^G9).
Each band was assigned according to its DP value and according to
standard oligosaccharides from ribonuclease (Man-5 to Man-9, lane
5) and peroxidase (lane 6). Band identi¢cations are indicated in the
margins of the ¢gure. B: Theoretical structures of N-glycans linked
to rGL. b Man; E GlcNAc; 7 Fuc; a Xyl.
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(50 kDa) [27]. The recombinant secreted proteins have an
N-terminal sequence, which corresponds to correct N-terminal
processing of the protein. For v-rGL two molecular species
were detected, a major one around 41 kDa and a minor one at
about 49 kDa. N-terminal sequencing revealed the presence of
two protein sequences, a minor one corresponding to the full-
length protein, whereas the dominant sequence corresponded
to a truncated form of GL beginning at amino acid Ile 55. A
more complex pattern was observed in the case of r-rGL. By
MALDI-TOF-MS, a very broad peak around 49 kDa was
detected together with a form around 41 kDa. This pattern
is consistent with the SDS^PAGE pro¢le that shows at least
three individual bands around 49 kDa. Western blotting with
a lipase-speci¢c antibody shows the same pattern of bands.
Incubation of the blot with an anti-KDEL antibody does not
show a correlation of these bands to a potential proteolytic
cleavage of the KDEL sequence (data not shown). A trun-
cated form of the protein starting at Ile 55 was detected by
N-terminal sequencing together with the full-length protein.
These results indicate the presence of heterogeneous forms of
rGL after targeting to the ER. The relative broadness of the
peaks in MALDI-TOF-MS spectra is a ¢rst indication of a
potential heterogeneity of the di¡erent forms of rGL that
could eventually be attributed to di¡erences in glycosylation.
3.4. Analysis of N-glycosylation of rGLs by FACE
GL has four potential N-glycosylation sites located on Asn
15, Asn 80, Asn 252 and Asn 308. To study the extent of
N-glycosylation on the total protein, the di¡erent rGLs were
submitted to FACE analysis [21]. A large number of di¡erent
but typical plant N-glycans were found. High-mannose-type
N-glycans from Man-6 to Man-9 and complex-type N-gly-
cans, type a, b and c containing fucose and xylose residues
attached to the core structure, were identi¢ed (Fig. 2A,B).
Intermediate complex structures lacking fucose residue were
also detected. These structures were named type aP, bP and cP.
Type aP was clearly resolved on the gel. Due to lower resolu-
tion, types bP and cP migrate at the same positions as type b
and type c, respectively, and their presence could only be
con¢rmed by MALDI-TOF-MS analysis of the isolated gly-
can bands (data not shown).
Although each rGL contains the two classes of N-glycans,
the relative proportion of high-mannose and complex struc-
tures di¡ers from one targeting to the other. Whereas s-rGL
contains more complex-type N-glycan (c+cP) than v-rGL,
‘truncated’ structures types a and (b+bP) (lacking one or
two GlcNAc terminal residues) are the dominant complex
structures in v-rGL (Fig. 2, lanes 1 and 2). When rGL is
directed to the ER, Man-8 becomes the major high-man-
nose-type structure (Fig. 2, lane 3). These data correlate
with the theoretical N-glycosylation processing in plants
[28]. Nevertheless, a clear-cut di¡erence of glycosylation pat-
terns for the three proteins is not found since r-rGL displays
complex structures in relatively high proportion and s-and
v-rGL high-mannose-type structures.
3.5. Site-speci¢c analysis of N-glycosylation by
MALDI-TOF-MS
To further elucidate the glycan structures present on each
N-linked glycosylation site of the rGLs obtained after di¡er-
ential targeting, tryptic digests of the proteins were analyzed
by MALDI-TOF-MS. Trypsin produced glycosylated peptides
which could be analyzed by mass spectrometry on a relatively
narrow mass range (m/z 4000^8500). Glycosylation on the
four potential glycosylation sites could thus be compared
easily in situ without peptide isolation and deglycosylation.
Table 1
Theoretical masses of tryptic glycosylated peptides of recombinant GL
UNa Man-5 Man-6 Man-7 Man-8 Man-9 a b c aP bP cP aQ
Asn 15 4647.2 5864.3 6026.5 6188.6 6350.8 6512.9 5818.3 6021.5 6224.7 5672.1 5875.3 6078.5 5686.2
Asn 80 4685.3 5902.4 6064.6 6226.7 6388.9 6551.0 5856.4 6059.6 6262.8 5710.3 5913.4 6116.6 5724.3
Asn 252 2922.4 4139.6 4301.7 4463.8 4626.0 4788.1 4093.5 4296.7 4499.9 3947.4 4150.6 4353.8 3961.4
Asn 308 6329.2 7546.3 7708.4 7870.6 8032.7 8194.9 7500.3 7703.5 7906.6 7354.1 7557.3 7760.5 7368.1
Each glycopeptide is de¢ned by its glycosylation position along the peptidic chain (Asn 15, Asn 80, Asn 252, Asn 308) which corresponds to a
speci¢c tryptic peptide. Expected glycosylation pattern (high-mannose or complex-type, see Fig. 2B for detailed structures) are supposed for
each tryptic peptide, and theoretical masses are calculated from these expected tryptic peptides. Average masses are expressed as [M+H]þ.
Numbers in bold correspond to identi¢ed structures.
aUN: unglycosylated peptide.
Table 2
Relative amounts of N-glycans detected on s-rGL, r-rGL and v-rGL N-glycosylation sites
UN Man-5 Man-6 Man-7 Man-8 Man-9 a b c aP bP cP aQ
Asn 15 s-rGL 6 5 15 15 10 20 15 ^ ^ ^ 10 10 6 5 ^
r-rGL 5 6 5 5 10 50 10 ^ ^ ^ 6 5 10 5 ^
v-rGL 5 ^ 10 10 30 20 ^ ^ ^ 5 15 5 ^
Asn 80 s-rGL ^ ^ ^ 6 5 6 5 ^ 30 45 15 ^ ^ ^ 5
r-rGL ^ ^ ^ ^ 30 ^ 30 35 ^ ^ ^ ^ 5
v-rGL ^ ^ ^ 6 5 6 5 ^ 45 40 ^ ^ ^ ^ 15
Asn 252 s-rGL ^ ^ ^ 20 45 35 ^ ^ ^ ^ ^ ^ ^
r-rGL ^ ^ ^ 20 40 40 ^ ^ ^ ^ ^ ^ ^
v-rGL ^ ^ ^ 15 40 45 ^ ^ ^ ^ ^ ^ ^
Asn 308 s-rGL 10 ^ ^ ^ 6 5 ^ 40 30 15 ^ ^ ^ ^
r-rGL 20 ^ ^ ^ 25 ^ 30 25 6 5 ^ ^ ^ ^
v-rGL 15 ^ ^ ^ ^ ^ 50 30 6 5 ^ ^ ^ ^
Glycosylated peptides were estimated for each glycosylation site. Relative amounts of oligosaccharide structures are expressed as percent
(rounded to the nearest 5%). Data are representative of three experiments. See Fig. 2B for detailed structures.
^: not detected.
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N-glycan assignment was realized by comparison between cal-
culated and measured masses for each theoretical tryptic pep-
tide. The interpretation is based on a good correlation be-
tween a series of calculated masses and experimental values
for a given tryptic peptide (Table 1). The four sites were found
glycosylated. The N-glycopeptides containing the potential
N-glycosylation sites Asn 15, Asn 80, Asn 252 and Asn 308
were clearly identi¢ed (Fig. 3) and only a very small fraction
of peptides corresponding to Asn 15 and Asn 308 were non-
glycosylated. A minor fraction of oxidized peptides was de-
tected (M+16, not indicated in Fig. 3).
Independent of the subcellular targeting, each site displays a
speci¢c glycosylation pattern (Fig. 3 and Table 2). Peak in-
tensities in mass spectra are calibrated to the most intense ion.
In the case of r-rGL, with Man-8 representing a very intense
ion, the peak intensities of complex glycan structures appear
weaker than for other targetings (Fig. 3). For each of the
three di¡erent targetings Table 2 gives the relative amount
of a given glycan structure in % of the total glycan structures
for a speci¢c glycosylation site. Each line represents 100% of a
given peptide for a speci¢c targeting. Asn 80 and Asn 308
were mainly glycosylated with complex-type N-glycans includ-
ing types a, b and c. In addition, Asn 80 is the only site that
contains complex-type aQ. Asn 252 was only glycosylated with
high-mannose-type N-glycans, Man-7, Man-8 and Man-9.
Asn 15 displayed a more complex glycosylation pattern; it
Fig. 3. MALDI-TOF analysis of rGL tryptic digests. Tryptic peptide mixtures were analyzed directly using SIN as matrix. Theoretical glycosyl-
ation was calculated for each potential glycosylation site (Table 1). P Tryptic peptide corresponding to Asn 15 glycosylation site; 8 tryptic
peptide corresponding to Asn 80 glycosylation site; b tryptic peptide corresponding to Asn 252 glycosylation site; D tryptic peptide corre-
sponding to Asn 308 glycosylation site; T, trypsin autolytic peptide. Each glycosylated form was identi¢ed as high-mannose-type (Man-5 to
Man-9) or as complex-type (a, b, c, aP, bP, cP, aQ). See Fig. 2B and Table 1 for structure assignment and Table 2 for relative amounts of N-gly-
cans. Non-assigned peaks correspond to other tryptic peptides of the protein.
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was linked to high-mannose-type N-glycans (Man-5 to Man-
9) but also to non-fucosylated complex-type N-glycans aP, bP
and cP. Whereas each of the sites displays its speci¢c pattern
of glycosylation, some appear also partly in£uenced by the
targeting. Asn 80 and 308 of s-rGL contain higher amounts
of complex-type c than for vacuolar or ER targeting (Table 2
and Fig. 3). An increase in types a and b for v-rGL and r-rGL
compensates this decrease at least in part, which correlates to
the data observed by FACE analysis. v-rGL has a higher
amount of type aQ on Asn 80. When directed to the ER, a
clear increase of high-mannose-type N-glycan Man-8 is ob-
served on Asn 15, Asn 80 and Asn 308. Glycosylation of
Asn 252 is not in£uenced by the targeting; whatever the tar-
geting, high-mannose-type structures with roughly identical
percentages were detected.
The relative proportions of certain glycopeptides di¡er ac-
cording to the targeting of the proteins (i.e. r-rGL having a
higher amount of high-mannose-type N-glycans) but the type
of glycans found appears to be more site-speci¢c than target-
ing-speci¢c (Table 2).
4. Discussion
The choice of a recombinant expression system for the pro-
duction of a therapeutic protein is in£uenced by several tech-
nical, economical and regulatory parameters. The initial ques-
tion to be answered is whether a given expression system can
produce the molecule in an active form that can be adminis-
tered to the patient. Characteristics such as integrity, con-
formity, activity, immunogenicity and stability of the protein
have to be elucidated. Our aim was to test a transient tobac-
co-based expression system that allows validation of the pro-
duction of a given recombinant product in plants in a mini-
mum of time and with a maximum level of ¢delity as
compared to results obtained in stable plants. This system
has previously been used to validate the expression of anti-
body molecules [9,29], or to study the possibility to metabol-
ically engineer plant cells to improve the thermal stability of
recombinant human collagen [8]. In the latter case, results
obtained by transient expression were highly reproducible
and predictive for the biochemical quality of protein obtained
in stable plants.
In this study we performed a detailed analysis of di¡eren-
tially targeted recombinant lipases and their N-glycosylation
patterns after puri¢cation from transiently transformed tobac-
co without going through the time-consuming creation of sta-
ble tobacco lines. GL is a highly glycosylated globular protein
[30,31] of approximately 50 kDa containing four N-glycosyl-
ation sites localized on Asn 15, Asn 80, Asn 252 and Asn 308.
We have previously shown that targeting of GL to two di¡er-
ent subcellular locations in stable tobacco had a signi¢cant
in£uence not only on the structure of the molecule, but also
on its catalytic activity [11]. In [11] it was also shown by
immuno-gold labeling that the secreted form of rGL is found
in the apoplast, while v-rGL accumulates in the vacuole. The
results obtained for secretion and vacuolar targeting in tran-
sient expression con¢rm these results. As for stable tobacco a
large proportion of v-rGL is cleaved between amino acids Asn
54 and Ile 55, thus con¢rming its vacuolar targeting. This
cleavage can be attributed to proteases that are located in
the plant vacuole [32,33] and appears to be related to a pro-
teolytic sensitivity of this peptide bond in pre-duodenal lipases
[34]. Although it appears that the N-terminal peptide remains
associated to the rest of the molecule in the non-denatured
globular structure [11] it is readily detached under denaturing
conditions in SDS^PAGE and MALDI-TOF-MS. This pro-
teolytic instability of v-rGL has an in£uence on the catalytic
activity of the molecule, which loses more than 50% of its
activity as compared to the secreted s-rGL. It therefore ap-
pears to be obvious that secretion, but not vacuolar targeting,
would be the better choice for production of GL in plants.
Interestingly, a large proportion of r-rGL which is suppos-
edly blocked in the ER through its KDEL C-terminal se-
quence also shows a cleavage between amino acids Asn 54
and Ile 55. This could be an indication for the leakiness of
this targeting and might indicate that r-rGL is partly shuttled
to the vacuole, a result which has already been described by
Gomord et al. [35]. Although we did not express r-rGL in
stable tobacco, it again appears obvious that targeting to
the ER is not a viable expression hypothesis for this enzyme.
GLs were already expressed in heterologous organisms such
as E. coli [10], insect cells [36] or stable tobacco plants [11],
but the exact structures of N-glycan chains of the native or the
recombinant enzymes were, to our knowledge, not investi-
gated.
The puri¢ed s-, v- and r-rGL from transient expression in
tobacco allowed us to perform this analysis. Our aim was
thereby to compare the glycan structures on recombinant pro-
teins produced by di¡erential targeting in plants and not to
elucidate the glycan structure of recombinant versus native
protein. FACE data on the overall glycan composition of
the di¡erent forms of lipase con¢rmed the presence of a large
number of di¡erent glycan structures. This important hetero-
geneity of plant glycan structures has already been described
for several plant proteins. See for example Lerouge et al. [28]
and references cited therein. Our FACE analysis does not
show a clear-cut distinction of glycan structures in relation
to the targeting of the protein. In particular, complex and
truncated structures were found in the ER-directed protein,
suggesting a leakage through other compartments [35]. The
presence of truncated complex glycan structures on s-rGL
can be explained by the presence of exoglycosidases in the
apoplast [28,37]. It does not necessarily indicate a transport
of s-rGL to the vacuole, which is also con¢rmed by the lack
of the Ile 55 truncation in this secreted form of rGL. In gen-
eral the FACE technique does not allow a detailed site-speci¢c
comparison of structures, but gives a ¢rst appreciation of the
overall glycosylation pattern in relation to di¡erential target-
ing.
A more precise identi¢cation of the glycan structures on GL
could be obtained through a site-by-site in situ analysis by
MALDI-TOF-MS on tryptic digests of the di¡erentially tar-
geted molecules. In the case of this study this was a very fast
and easy procedure which did not require isolation of the
individual glycopeptides or deglycosylation of the protein.
For other proteins additional isolation of glycopeptides
or additional mass ranges might be required for MS analysis
of the structures. Each of the four glycosylation sites has
its characteristic pattern of glycan structures. Data from
MALDI-TOF-MS and FACE analysis are complementary
but a direct comparison of relative values from MALDI-
TOF-MS and band intensities from the FACE gel is not pos-
sible. Complex form c for r-rGL, for example, represents only
a low relative intensity in the MALDI-TOF-MS analysis of
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Fig. 3, while a band representing total (c+cP) forms of r-rGL
is clearly visible in the FACE gel (Fig. 2).
Asn 15 contains high-mannose glycans as well as complex-
type glycans aP, bP and cP and a minor percentage of non-
glycosylated residues. Asn 80 and Asn 308 contain predom-
inantly complex structures and only few high-mannose forms.
Asn 252 is only linked to high-mannose-type glycans. Apart
from some quantitative di¡erences, the glycan structures on a
given site are independent of the targeting of the molecule.
Asn 15, for example, in all cases contains a mixture of high-
mannose and complex-glycans while Asn 252 always contains
only high-mannose-type glycans. The processing of the glycan
side-chains is closely related to their accessibility to the gly-
cosyltransferases in the Golgi [28,38,39]. It therefore appears
obvious that Asn 252, after having been glycosylated with
high-mannose-type glycans, is buried within the tertiary struc-
ture of the molecule in a way that prohibits further modi¢ca-
tion of the structures.
The site-by-site analysis of glycan structures after di¡eren-
tial targeting of lipase as a model enzyme indicates that, at
least for this protein, the biochemical and/or physical environ-
ment of the Asn residue has a signi¢cantly greater impact on
the sugar structures that are added to the polypeptide chain
than the di¡erential routing of the protein through the com-
partments of the cell.
In conclusion, our transient expression system allowed us to
purify su⁄cient amounts of recombinant protein to perform a
functional and structural analysis of the di¡erentially targeted
molecules and to select the best targeting approach for a given
protein without the necessity to produce stable transformed
plants.
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